• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An Interesting Case of Refractory Kawasaki Disease With Co-infection.一例合并感染的难治性川崎病的有趣病例。
Cureus. 2024 Jun 5;16(6):e61726. doi: 10.7759/cureus.61726. eCollection 2024 Jun.
2
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.儿童川崎病的药物干预:56项随机对照试验的网状Meta分析
EBioMedicine. 2022 Apr;78:103946. doi: 10.1016/j.ebiom.2022.103946. Epub 2022 Mar 17.
3
Do cytokines correlate with refractory Kawasaki disease in children?细胞因子与儿童难治性川崎病是否相关?
Clin Chim Acta. 2020 Jul;506:222-227. doi: 10.1016/j.cca.2020.03.014. Epub 2020 Mar 7.
4
Intravenous immunoglobulin for the treatment of Kawasaki disease.静脉注射免疫球蛋白治疗川崎病。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
5
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.川崎病患者早期静脉注射免疫球蛋白治疗。
J Pediatr. 2002 Apr;140(4):450-5. doi: 10.1067/mpd.2002.122469.
6
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.急性川崎病的治疗:重新审视阿司匹林在发热阶段的作用。
Pediatrics. 2004 Dec;114(6):e689-93. doi: 10.1542/peds.2004-1037. Epub 2004 Nov 15.
7
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.多中心、随机、开放标签、盲终点评估的皮质类固醇加静脉注射免疫球蛋白(IVIG)和阿司匹林与 IVIG 和阿司匹林预防川崎病(KD)冠状动脉瘤(CAA)的试验:KD CAA 预防(KD-CAAP)试验方案。
Trials. 2023 Jan 26;24(1):60. doi: 10.1186/s13063-022-07051-9.
8
Kawasaki disease: a comprehensive review of treatment options.川崎病:治疗选择的全面综述
J Clin Pharm Ther. 2015 Dec;40(6):620-5. doi: 10.1111/jcpt.12334. Epub 2015 Nov 7.
9
High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more.高剂量与低剂量静脉注射免疫球蛋白治疗体重25公斤及以上川崎病患儿的疗效比较
Eur J Pediatr. 2020 Dec;179(12):1901-1907. doi: 10.1007/s00431-020-03794-2. Epub 2020 Aug 29.
10
Kawasaki disease in Sicily: clinical description and markers of disease severity.西西里岛的川崎病:临床描述与疾病严重程度标志物
Ital J Pediatr. 2016 Nov 2;42(1):92. doi: 10.1186/s13052-016-0306-z.

本文引用的文献

1
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
2
Kawasaki Disease.川崎病。
J Am Coll Cardiol. 2016 Apr 12;67(14):1738-49. doi: 10.1016/j.jacc.2015.12.073.
3
Kawasaki disease in association with urinary tract infection.川崎病合并尿路感染。
Indian Pediatr. 2011 Oct;48(10):808-9.
4
Pathogenesis of Kawasaki disease.川崎病的发病机制。
Clin Exp Immunol. 2011 May;164 Suppl 1(Suppl 1):20-2. doi: 10.1111/j.1365-2249.2011.04361.x.
5
Pyuria is not always sterile in children with Kawasaki disease.川崎病患儿的脓尿并不总是无菌的。
Pediatr Int. 2010 Feb;52(1):113-7. doi: 10.1111/j.1442-200X.2009.02884.x. Epub 2009 May 18.
6
Detection of human bocavirus in children with Kawasaki disease.川崎病患儿中人博卡病毒的检测
Clin Microbiol Infect. 2007 Dec;13(12):1220-2. doi: 10.1111/j.1469-0691.2007.01827.x. Epub 2007 Sep 10.
7
Infections and Kawasaki disease: implications for coronary artery outcome.感染与川崎病:对冠状动脉转归的影响
Pediatrics. 2005 Dec;116(6):e760-6. doi: 10.1542/peds.2005-0559.
8
Kawasaki disease: what is the epidemiology telling us about the etiology?川崎病:流行病学能告诉我们哪些关于病因的信息?
Int J Infect Dis. 2005 Jul;9(4):185-94. doi: 10.1016/j.ijid.2005.03.002.
9
Kawasaki syndrome.川崎病
Lancet. 2004;364(9433):533-44. doi: 10.1016/S0140-6736(04)16814-1.
10
Active or recent parvovirus B19 infection in children with Kawasaki disease.
Lancet. 1994 May 21;343(8908):1260-1. doi: 10.1016/s0140-6736(94)92154-7.

一例合并感染的难治性川崎病的有趣病例。

An Interesting Case of Refractory Kawasaki Disease With Co-infection.

作者信息

Kumar Ratan, Mishra Adyasha, Diwakar Kumar, Tanti Sanjay K

机构信息

Pediatric Intensive Care Unit, Tata Main Hospital, Jamshedpur , IND.

Pediatrics, Tata Main Hospital, Jamshedpur, IND.

出版信息

Cureus. 2024 Jun 5;16(6):e61726. doi: 10.7759/cureus.61726. eCollection 2024 Jun.

DOI:10.7759/cureus.61726
PMID:38975482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11225639/
Abstract

Kawasaki disease (KD), formerly called mucocutaneous lymph node syndrome, is one of the common vasculitides of childhood. KD most commonly occurs in children over six months up to five years of age, although it can occur in young infants, older children, and adults. Early diagnosis is critical to achieving optimal treatment. We present a case of a three-year-old female child who was admitted with a fever for five days and fulfilled the diagnostic clinical criteria for KD. She was given intravenous immunoglobulin (IVIG) and aspirin. However, the fever persisted, and a urine culture showed the growth of Klebsiella pneumoniae. We started an antibiotic based on her sensitivity. Since fever spikes were not subsiding, she was given a repeat dose of IVIG along with an oral corticosteroid for refractory KD, after which she showed clinical improvement. This case highlighted that refractory KD can coexist with infection.

摘要

川崎病(KD),以前称为皮肤黏膜淋巴结综合征,是儿童常见的血管炎之一。KD最常发生于6个月至5岁的儿童,不过也可发生于幼儿、大龄儿童及成人。早期诊断对于实现最佳治疗至关重要。我们报告一例3岁女童,因发热5天入院,符合KD的诊断临床标准。给予其静脉注射免疫球蛋白(IVIG)和阿司匹林。然而,发热持续存在,尿培养显示肺炎克雷伯菌生长。根据药敏结果开始使用抗生素。由于高热未消退,给予她重复剂量的IVIG以及口服糖皮质激素治疗难治性KD,之后她的临床症状有所改善。该病例突出表明难治性KD可与感染并存。